Table of Contents
GUEST EDITORIAL
How will the COVID crisis affect our practice? 1
Carlos G. Naval, MD, MBA
Emerging IOL Technology in the Digital Age 3
Richard C. Kho, MD
SPECIAL COMMUNICATION
Retinal Toxicity and the Use of Hydroxychloroquine and Chloroquine in the
Current Management of COVID-19
An Updated Advisory for Ophthalmologists and Other Health Care Professionals (March 28, 2020) 6
Romulo N. Aguilar, MD, PhD, Paolo Antonio S. Silva, MD, Recivall P. Salongcay, MD, Cheryl A. Arcinue, MD,
Franz Marie Cruz, MD, Rory King Go, MD, Vitreo-Retina Society of the Philippines
ORIGINAL RESEARCH
Survey of Glaucoma Practice Patterns Among Members of
The Philippine Glaucoma Society 9
Edgar Felipe U. Leuenberger, MD, DPBO, James Paul S. Gomez, MD, DPBO,
Karlo Paolo L. Alejo, MD, DPBO, Robert Edward T. Ang, MD, DPBO,
Maria Zita Zagala-Meriales, MD, DPBO, Pamela C. Allarey, MD, DPBO,
Aldo Mar B. Cariaga, MD, DPBO, John Mark S. De Leon, MD, DPBO,
Sammy L. Ang, MD, DPBO, For the Philippine Glaucoma Society
Rate of Progression of Visual Field Loss in Primary Open Angle Glaucoma
Versus Primary Angle Closure Glaucoma Patients Managed in a Tertiary Hospital 19
Jesa Nadine V. Protasio, MD, Nilo Vincent DG. FlorCruz II, MD
A Comparative Evaluation of Visual, Refractive, and Patient-Reported
Outcomes of Three Diffractive Trifocal Intraocular Lenses 28
Robert Edward T. Ang, MD, Janice Marie N. Jordan-Yu, MD, Mark Sylvester F. Agas, MD,
Ryan S. Torres, MD, Emerson M. Cruz, MD
Comparative Analysis of Meibomian Gland Dysfunction in Eyes
with and without Eyelid Margin Tattoos 41
Ma. Joanna Carla Z. Garcia, MD, Edgar U. Leuenberger, MD, DPBO, James Paul S. Gomez, MD, DPBO,
Tommee Lynne T. Tiu, MD, DPBO, Sharlene I. Noguera, MD, DPBO
Methotrexate for Sympathetic Ophthalmia: A Report of 3 Cases 48
Corrina P. Azarcon, MD, Franz Marie Cruz, MD, Teresita R. Castillo, MD, Cheryl A. Arcinue, MD